Tag /

Fat

Omega-3 fatty acids featured article

Introduction

Omega-3 fatty acids are polyunsaturated fats that play critical roles in human health, participating in a wide range of biochemical pathways and processes and modulating the expression of genes throughout the lifespan. Omega-3 fatty acids include plant-derived alpha-linolenic acid (ALA) and marine-derived eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), among others. A growing body of evidence indicates that omega-3 fatty acids may prevent or ameliorate symptoms associated with chronic health conditions such as cardiovascular disease, neurodegenerative disease, and rheumatoid arthritis and may be beneficial in combating aging-related diseases.

Although ALA plays important roles in human health, this article focuses primarily on the beneficial effects of the marine-derived omega-3 fatty acids, EPA and DHA.

Effects at a glance

Research demonstrates that omega-3 fatty acids exert a multitude of effects on health and aging,...

Episodes

Posted on November 19th 2024 (7 months)

Dr. Rhonda Patrick discusses silicone safety, grounding, pentadecanoic acid, and the potential benefits of olive leaf extract and peptides.

Posted on September 30th 2024 (9 months)

In this clip, Dr. Layne Norton discusses seed oils, health risks, and the benefits of olive oil for heart health.

Posted on October 4th 2023 (over 1 year)

In this clip, Dr. Martin Gibala outlines the relationship between exercise types, mitochondrial growth, and their combined effect on fat metabolism.

Topic Pages

We haven't published any topic pages associated with this tag yet!

News & Publications

  • Fat is a vital energy source, but when consumed in excess, it can promote obesity. However, the amount of fat the body absorbs may be more related to the brain than the gut. A recent study in mice found that signals from the brain’s vagus nerve regulate fat uptake in the intestine, offering a potential means to moderate obesity.

    Researchers manipulated the dorsal motor nucleus of the vagus (DMV), which plays a crucial role in digestion. They inactivated DMV neurons that connect to the jejunum (the middle portion of the intestine), shortening the length of the microvilli in the gut and reducing fat absorption. However, stimulating DMV neurons increased fat absorption and promoted weight gain. Finally, they injected mice with puerarin, a bioactive compound derived from the kudzu plant, and found that the compound mimicked the effect of DMV suppression, further reducing fat absorption.

    These findings suggest that controlling the DMV-vagus-jejunum pathway could provide a novel approach to managing fat absorption and weight. They also highlight yet another way the brain-gut axis influences human health.

    Puerarin is an isothiocyanate, a class of sulfur-containing compounds known for their potent anti-inflammatory, anti-cancer, and anti-obesity effects. Sulforaphane, another well-known isothiocyanate, shares many of these beneficial properties. To learn more about the health effects of sulforaphane, check out our overview article.

  • Roughly one-tenth of postmenopausal breast cancers are linked to high body mass index (BMI)—a measure of excess body fat. However, BMI is unreliable, especially in older women, because it doesn’t account for age, sex, or ethnicity. Using newer, more accurate body fat assessments, a recent study predicted that nearly 40% of breast cancers are due to excess body fat.

    The study involved 1,033 women with breast cancer and 1,143 women without. Researchers calculated their body fat using BMI and CUN-BAE, a body fat estimator that accounts for age and sex. Then, they calculated the proportion of breast cancer cases linked to body fat.

    They found that 23% of postmenopausal breast cancer cases were linked to excess body fat when assessed by BMI, but the estimate jumped to 38% with CUN-BAE. Among women with hormone receptor-positive tumors, CUN-BAE indicated a striking 41.9% of cases were attributable to excess body fat—more than double the 19.9% predicted with BMI.

    These findings suggest that using BMI alone underestimates the cancer burden from excess body fat, especially for hormone receptor-positive breast cancer. Approximately 43% of postmenopausal women in the U.S. have obesity, markedly increasing their risk for breast cancer. Sulforaphane, a bioactive compound derived from broccoli, exerts potent anticancer effects. Learn more in this episode featuring Dr. Jed Fahey.

  • Although many factors influence whether a person develops neurodegenerative diseases like Alzheimer’s and other forms of dementia, excess body fat stands out as a notable risk factor. Some research suggests that where that body fat is located modulates that risk, with a new study finding that higher body fat in the arms and belly increases the likelihood of neurodegenerative disease.

    The study involved more than 412,000 people enrolled in the UK Biobank study. Researchers measured the participants' body composition and tracked their health for about nine years.

    They found that participants with greater muscle strength, bone density, and body fat in their legs were 6% to 25% less likely to develop neurodegenerative diseases. However, those with more body fat in their arms and bellies were 13% to 18% more likely to develop neurodegenerative diseases. Between 10% and 35% of the link between these body composition patterns and neurodegenerative diseases was attributable to the influence of cardiovascular diseases—particularly cerebrovascular diseases.

    Cerebrovascular disease is an umbrella term for conditions that affect the blood vessels that supply the brain, such as strokes and aneurysms. Exercise helps maintain the health of these blood vessels, reducing the risk of neurodegenerative diseases. Learn more in this episode featuring Dr. Axel Montagne.

  • Carbohydrates are the principal driver of insulin secretion, facilitating the uptake and metabolism of this macronutrient. However, a recent study found that fats and proteins also stimulate insulin secretion, potentially affecting people with type 2 diabetes.

    Researchers collected pancreatic islet cells responsible for insulin secretion from 140 donors after their deaths. About half of the donors had type 2 diabetes. They exposed the cells to carbohydrates, fats, and proteins and assessed insulin secretion.

    They found that most donors' islet cells exhibited a robust insulin response to carbohydrates, a moderate response to protein, and a low response to fat. However, some donors' cells elicited responses to protein (9%) and fat (8%) greater than their response to carbohydrates. Cells from donors with type 2 diabetes exhibited diminished responses to carbohydrates and fats, but their protein response was preserved.

    These findings suggest that insulin responses to macronutrients differ among individuals, with some preferentially responding to proteins and fats over carbohydrates. They also suggest that higher protein diets could benefit people with type 2 diabetes. Some evidence suggests that current guidelines for protein intake are too low, with implications for people more responsive to protein. Learn more about protein requirements in this clip featuring Dr. Stuart Philips.

  • Fat tissue produces leptin, a hormone that communicates with the brain to regulate energy balance. When fat mass increases, leptin levels in the blood also rise, signaling the brain to curb appetite and increase energy use. However, in obesity, the body’s sensitivity to leptin is reduced, blunting these regulatory effects. A recent study in mice found that vitamin D allocates excess calories to muscle growth instead of fat storage by regulating leptin and myostatin, a hormone involved in muscle growth.

    Researchers fed mice diets containing low, moderate, or high doses of vitamin D for four weeks to induce deficient, normal, and high vitamin D concentrations, respectively. Then, they measured changes in the animals' blood concentrations of leptin and myostatin and assessed their strength.

    They found that high doses of vitamin D increased leptin production and sensitivity while decreasing myostatin production. These changes elicited a greater allocation of excess calories to muscle and linear growth instead of fat storage.

    These findings suggest that high-dose vitamin D could effectively manage obesity and related conditions by redirecting calories from fat storage to muscle growth. They also highlight the interplay between vitamin D, leptin, and myostatin. Learn more about vitamin D in our comprehensive overview article.

  • Obesity, which affects more than 40 percent of U.S. adults, arises when the body stores excess fat, primarily in adipose tissue. While adipose tissue is an important source of energy, its capacity to produce energy in the setting of obesity diminishes, complicating weight loss efforts. A recent study demonstrates that obesity promotes fragmentation of the mitochondria in adipose cells, resulting in smaller and less effective mitochondria with reduced fat-burning capacity.

    Researchers fed mice an obesogenic diet and assessed its effects on their fat cells' mitochondrial function. Then, they analyzed gene activity in fat samples collected from people with obesity.

    They found that after eating a high-fat diet, mitochondria in the animals' adipose cells underwent fragmentation, forming smaller, less efficient mitochondria with diminished fat-burning capabilities. This metabolic alteration was orchestrated by the activity of RaIA, a molecule that serves various roles, one of which involves assisting in the breakdown of dysfunctional mitochondria. Deleting this gene in the mice prevented excessive weight gain despite consuming an obesogenic diet, highlighting RaIA’s crucial role in transitioning from a healthy weight to obesity. They also found evidence of increased gene activity in people with obesity that corresponded with persistent elevation in RalA.

    These findings suggest that obesity induces fragmentation of mitochondria, compromising their function and driving a vicious cycle of diminished fat-burning capability and increased body fat gain. Evidence suggests cold exposure and fasting promote weight loss. Learn more in this episode featuring Dr. Ray Cronise.

  • Excess body fat increases a person’s risk for many types of cancer. However, body fat distribution patterns tend to be sex-specific, with males carrying more fat in the upper abdomen and females carrying more in the hips, thighs, buttocks, and lower abdomen. A new study has identified differences in obesity-driven cancer rates between males and females.

    Researchers drew on data from more than 440,000 adults enrolled in the UK Biobank study. They used statistical analysis to determine how various measures of body fat, such as body mass index (BMI) and waist circumference, influenced the risk of developing 19 types of cancer over a follow-up period of about 13 years.

    They found that nearly all 19 cancers were associated with excess body fat, except brain, cervical, and testicular cancers. They also found that overall body fat had a greater influence on cancer risk than fat distribution. However, they noted sex-specific effects of body fat on colorectal, esophageal, and liver cancer rates between males and females. For example, excess abdominal fat increased the rates of esophageal cancer in females but not males. Similarly, excess overall fat increased the rates of liver cancer in males but not females.

    These findings suggest body fat plays important but differential roles in cancer risk between males and females. Evidence suggests a ketogenic diet promotes weight loss and reduces cancer risk. Learn more about ketogenic diets and cancer in this episode featuring Dr. Dominic D'Agostino.

  • A new study found that regular cycling may slow sarcopenia – the age-related loss of muscle mass and strength. Men who cycled regularly had larger, leaner gluteus muscles than inactive men.

    The study involved two groups of men: 28 who were physically inactive and had not practiced sports for an average of 27 years and 28 who were trained recreational male cyclists, had cycled more than 4,300 miles in the past year, and had been cycling for an average of 15 years. Researchers used magnetic resonance imaging to determine the volume of the participants' gluteus maximus and gluteus medius muscles, which are situated in and around the buttocks, as well as the percentage of fat infiltration within those muscles.

    They found that the inactive group tended to be heavier than the cyclists. They also found that the cyclists had larger gluteus maximus and gluteus medius muscles than the males in the inactive group. On average, the cyclists had 7 percent less fat infiltration in the gluteus maximus and 5 percent less in the gluteus medius than the males in the inactive group.

    Research suggests that physical inactivity promotes muscle fat infiltration and progressive muscle weakness, driving sarcopenia – the age-related loss of muscle tissue. However, exercise and appropriate nutritional support may forestall these muscle losses. Learn how exercise and dietary protein play roles in slowing age-related muscle loss in this episode featuring Dr. Stuart Phillips.

  • From the article:

    Santosa’s research compared fat storage in pre- and post-menopausal women. The 23 women who participated in the study were in the same age range, and had similar Body Mass Indices and body fat composition. These similarities allowed Santosa to isolate the effects of estrogen on fat absorption and storage.

    She and Jensen were able to examine the activity of certain enzymes and proteins that regulate fat storage in post-menopausal women’s abdomens and thighs. By considering these factors together rather than in isolation, the researchers determined conclusively that the overall fat storage “machinery” is more active in post-menopausal women. In other words, these cells now store more fat than they did before menopause.

    In addition, post-menopausal women burned less fat than their pre-menopausal colleagues. These changes mean that their cells are not only storing more fat, but are also less willing to part with it. This combination is a recipe for rapid weight gain. “Taken together, these changes in bodily processes may be more than a little surprising – and upsetting – for women who previously had little trouble managing their weight,” comments Santosa.

    Though the increased cellular activity revealed by this study was not specific to the abdominal region, more fat stored overall means more abdominal fat.

    From the publication:

    We found that meal FA [fatty acid] storage in subcutaneous fat was greater in postmenopausal than in premenopausal women. This difference was especially evident in the femoral depot, where meal FA [fatty acid] storage in postmenopausal women was double that of premenopausal women.

    […]

    The increase in fat storage stems from somewhat greater LPL [lipoprotein lipase] activity and significantly greater content of adipocyte FA [fatty acid] storage factors. It is possible that the upregulation in proteins associated with FA [fatty acid] storage capacity in postmenopausal women contributes to the decrease in postprandial total fat oxidation. Whether the differences in FA [fatty acid] storage between premenopausal and postmenopausal women are attributable to the effects of estrogen or the combination of estrogen, progesterone, and other factors, such as changing insulin concentrations, remains to be elucidated.

    View full publication

  • From the article:

    The hormonal effect seen in these mice relates at least in part to how the female body processes vitamin A, a nutrient that is converted into a variety of compounds. These include a molecule that supports the burning of fat for energy, as well as retinoic acid, the hormone in this study that leads to the formation of visceral fat. The scientists showed that a high-fat diet functions as a switching mechanism that breaks down the fat-burning molecule and leads to activation of the enzyme and production of retinoic acid, ending in the development of visceral fat.

    A year ago, Ziouzenkova’s lab identified the one of these enzymes that relates to fat accumulation: Aldehyde Dehydrogenase 1, or Aldh1a1. In the current study, she and colleagues conducted numerous experiments in mice to track the events that followed activation of this enzyme.

    The researchers compared normal mice with genetically altered mice lacking the enzyme over almost a year of eating a high-fat diet. Male and female normal mice gained weight on the high-fat diet, as expected, though the females developed more visceral fat that surrounds the organs than did males, a trend also seen in humans as the result of eating excess fat. (In contrast, on a regular diet, men are more likely than women to form abdominal fat.) Both sexes of mice developed peripheral subcutaneous fat, which lies just under the skin and has some benefits.

    In mice without the enzyme, however, the males developed some fat but females remained lean, and this occurred even when females ate more food than males. The researchers determined that without Aldh1a1, the females were not producing retinoic acid, and that protected them from producing visceral fat. Meanwhile, males retained the ability to produce retinoic acid.

    The scientists then analyzed the proteins contained in fat tissue in male and female mice lacking the enzyme, and saw that only the females' fat cells contained high levels of a protein that releases fat from fat cells to support fat burning. This release led to production of another protein that converts fat to heat, essentially burning the fat, in the form of lipids, away.

    “Without production of the hormone retinoic acid, females are burning fat and expending the energy in the form of heat. That’s why they stay very lean,” Ziouzenkova said. “And this process was specifically affecting visceral fat.”

    The researchers surgically removed the ovaries of mice to test whether estrogen could be related to visceral fat production in females. As soon as the animals became menopausal and weren’t producing estrogen, they began to produce retinoic acid, which led to visceral fat formation.

    Estrogen was sufficient to protect female mice from both hormonal and, partially, diet-induced obesity. This means estrogen is suppressing activation of the obesity-inducing hormone, and as soon as we lose this estrogen during menopause, the visceral fat starts to grow,” said Ziouzenkova, also an investigator in Ohio State’s Comprehensive Cancer Center.

    Using another mouse model that allowed researchers to measure hormone production specifically, the researchers observed that female mice on a regular diet barely produced retinoic acid. However, females on a high-fat diet produced high levels of the hormone and, in turn, showed a nine-fold increase in visceral fat compared to visceral fat developed by males on a high-fat diet. This was the final determinant that the high-fat diet triggers this cascade of events ending in visceral fat formation.

    Because the human fat tissue samples the researchers analyzed also showed elevated levels of Aldh1a1 in cells extracted from tissue in obese women, “it could be that what we show about this hormone’s importance to visceral obesity in mice is also true for humans,” Ziouzenkova said.

    View full publication

  • From the article:

    Estrogen receptors are located on cells throughout a woman’s body. Previous studies have shown that one type of estrogen receptor, known as estrogen receptor alpha or ER-alpha, plays a role in regulating food intake and energy expenditure. But scientists have been unable to pinpoint exactly where these fat-regulating receptors reside or how they work to govern these behaviors.

    To determine the effect of dwindling estrogen levels in the brain, Clegg and her colleagues are focusing on two ER-alpha rich regions located in the hypothalamus, an area of the brain that controls body temperature, hunger and thirst. The first region, called the ventromedial nucleus or VMN, is a key center for energy regulation.

    Using a relatively new gene-silencing technique called RNA interference, the researchers in earlier research deactivated the alpha-receptors in the VMN. The estrogen receptors in other regions of the brain maintained their normal capacity.

    When estrogen levels in the VMN dipped, the animals' metabolic rate and energy levels also plummeted. The findings show the animals quickly developed an impaired tolerance to glucose and a sizable weight gain, even when their caloric intake remained the same. What’s more, the excess weight went straight to their middle sections, creating an increase in visceral fat.

    The findings suggested that the ER-alpha in this region plays an essential role in controlling energy balance, body fat distribution and normal body weight.

    View full publication

  • From the article:

    “We know as women age and enter into menopause, they tend to gain body weight and body fat, particularly in the abdominal or ‘belly’ area. Excess abdominal fat greatly increases risk for cardio-metabolic diseases,” says Solomon. “While there are likely many factors that are associated with these risks in menopausal women, estrogen loss is associated with body weight and fat gain during menopause. In fact, estrogen treatment can offset this weight gain in many women.”

    The medial amygdala (MeA) is a region of the brain that helps regulate body weight and contains an abundance of estrogen receptors (molecules that respond to estrogen). The researchers used an experimental model in rats, which involves removing the ovaries to mimic the hormonal changes of menopause. They targeted estrogen replacement directly in the MeA and found that it prevented weight and abdominal fat gain and improved glucose tolerance, compared to rats in a placebo group. This suggests that the MeA is important in the metabolic health of menopausal females and may be a useful target for treatment.

    View full publication

  • From the article:

    Gavin and her colleagues recruited 17 overweight-to-obese premenopausal women, all between the ages of 18 and 44 years old. […] Participants performed this [submaximal] exercise both by itself and while the [fat-mobilizing] drugs were being infused. To test the effects of estrogen, the researchers also performed each of these conditions while estrogen was also being slowly infused into participants' fat deposits.

    Results

    The researchers found that estrogen’s effects differed tremendously depending on the fat-mobilizing interventions themselves and where the fat deposit was located. For example, estrogen blunted fat breakdown in the abdomen if it was infused while a particular fat-mobilization drug called isoproterenol was also being infused, but it didn’t have this effect in the buttocks. When a second fat mobilizing drug was given along with the first while participants were at rest, fat breakdown didn’t change any further. However, when both drugs were injected together during exercise or when the volunteers exercised without the drugs, fat breakdown increased in the abdomen, but less so in the buttocks.

    Importance of the Findings

    These results suggest that estrogen has different effects within fat tissue depending on its location. Together, these effects could help maintain premenopausal women’s “pear” shape even in the face of exercise or other signals the body receives to break down fat. They could also help generate some new ideas on how estrogen in fat may influence why postmenopausal women tend to accumulate more fat in the abdomen.

    View full publication

  • From the article:

    A strong correlation was found between sex hormones and body fat, which was predominantly due to shared genes. Specifically, testosterone and SHBG both showed a 23% genetic correlation with body fat, and SHBG [sex hormone-binding globulin] showed a 29% link with whole body fat. There was no link in terms of environmental factors between sex hormones and body composition.

    When measured individually, testosterone had the highest heritability estimate of the sex hormones at 0.65 (heritability estimates are measured on a scale between 0 and 1, with 1 equalling 100% genetic influence). SHBG, weight and body fat also had high heritability estimates of 0.73, 0.83 and 0.65, respectively. Such high heritability values are similar to those previously published, and indicate that circulating testosterone levels are approximately 60% influenced by genes.

    Previous studies have shown a well-established relationship between testosterone and body fat composition. For example, men with low testosterone levels are characterised by a high body fat percentage.

    View full publication

  • From the article:

    For the first 10 weeks, all participants were placed on a strict 600 kcal per day very-low calorie diet. They were also encouraged to abstain from alcohol and perform at least 30 minutes a day of moderate exercise. From the 11th through the 56th week, participants in both groups used a weight-maintenance diet based on the Australian Commonwealth Scientific and Industrial Research Organisation (CSIRO) Total Wellbeing Diet comprising of normal foods.

    Every 10 weeks over the 56-week-long study, 49 men also received injections of 1,000mg of intramuscular testosterone undecanoate, and 51 took placebo.

    At the end of 56 weeks, both groups lost roughly 11 kg (24.2 lb). But those in the testosterone group lost almost exclusively fat, while those on placebo lost both lean and fat. The men taking testosterone lost 3 kg (6.6 lb) more body fat than those on placebo and maintained their muscle mass, while those on placebo lost 3.5 kg (7.7 lb) of muscle mass.

    View full publication

  • Dietary interventions can change metabolite levels in the tumour microenvironment, which might then affect cancer cell metabolism to alter tumour growth. Although caloric restriction (CR) and a ketogenic diet (KD) are often thought to limit tumour progression by lowering blood glucose and insulin levels, we found that only CR inhibits the growth of select tumour allografts in mice, suggesting that other mechanisms contribute to tumour growth inhibition. A change in nutrient availability observed with CR, but not with KD, is lower lipid levels in the plasma and tumours. Upregulation of stearoyl-CoA desaturase (SCD), which synthesises monounsaturated fatty acids, is required for cancer cells to proliferate in a lipid-depleted environment, and CR also impairs tumour SCD activity to cause an imbalance between unsaturated and saturated fatty acids to slow tumour growth. Enforcing cancer cell SCD expression or raising circulating lipid levels through a higher-fat CR diet confers resistance to the effects of CR. By contrast, although KD also impairs tumour SCD activity, KD-driven increases in lipid availability maintain the unsaturated to saturated fatty acid ratios in tumours, and changing the KD fat composition to increase tumour saturated fatty acid levels cooperates with decreased tumour SCD activity to slow tumour growth. These data suggest that diet-induced mismatches between tumour fatty acid desaturation activity and the availability of specific fatty acid species determine whether low glycaemic diets impair tumour growth.

  • Obesity and metabolic diseases are strong risk factors for the development and progression of metastatic breast cancers in women who have completed menopause. Breast tumors contain a large number of white blood cells and adipocytes (i.e., fat cells); however, the role of adipocytes in metastatic breast cancer is unknown. Findings of a new report show that adipocytes shed molecular droplets called exosomes that relay cancer-promoting signals.

    Adipocytes play a critical role in the tumor microenvironment, releasing proinflammatory cytokines such as interleukin-6 and tumor necrosis factor-alpha and fats that act as fuel for tumor growth. Tumor metastasis is induced by changes in gene expression that increase cell movement and angiogenesis (i.e., the growth of new blood vessels) and decrease cell death and adhesion (i.e., how tightly cells cling to each other). The mechanisms by which adipocytes deliver these pro-cancer and pro-metastatic signals is understudied.

    The investigators obtained estrogen receptor-positive breast cancer cells and co-cultured them with adipocytes that were collected from female patients with or without type 2 diabetes who underwent bariatric (weight-loss) surgery. The researchers measured changes in gene and protein expression and performed fluorescence imaging to observe physical changes to adipocytes and cancer cells.

    When cultured with adipocytes from patients with obesity, cancer cells increased expression of genes important for a process called epithelial-to-mesenchymal transition, a key stage of tumor metastasis. Compared to exosomes produced by adipocytes from participants without type 2 diabetes, exosomes from participants with diabetes increased the expression of metastasis genes in cancer cells to a greater extent. Microscope imaging revealed that cancer cells from participants with diabetes underwent physical changes associated with metastasis as well as gene expression.

    These results revealed that exosomes shed from adipocytes act as the mechanism for delivery of pro-cancer compounds from adipocytes to breast cancer cells. Also, the strength of this pro-cancer signaling increased as insulin resistance increased. This study provides important insight into the relationship between obesity and cancer.

  • Heart disease is the number one cause of death in the United States, owing to a constellation of risk factors including a sedentary lifestyle, disrupted sleep patterns, stress, and poor diet. The average American adult consumes 29 grams of saturated fat per day (the amount in about four tablespoons of butter, four slices of pepperoni pizza, or 1.5 cups of ice cream), possibly contributing to heart disease risk through interactions with the gut microbiota. Findings of a new report link high saturated-fat diets to increased heart disease biomarkers among mice with high levels of E. coli bacteria.

    The gut microbiota, the community of bacteria, archaea, fungi, and viruses that lives in the human intestine, is highly influenced by changes in diet. Dietary fats that are not absorbed in the small intestine travel to the large intestine where microbes metabolize them. The same is true for other nutrients not absorbed by the gut, including choline, an essential nutrient found in high amounts in organ meats, egg yolks, and legumes. Choline is an important component of cellular membranes, a precursor for the production of neurotransmitters, and is incorporated into bile acids needed for the digestion of fats; however, some gut microbes convert choline into trimethylamine (TMA), which is absorbed by the intestine and converted to trimethylamine N-oxide (TMAO) in the liver. High serum levels of TMAO have been shown to increase the risk of major cardiovascular events such as heart attack and stroke by increasing the deposition of cholesterol in arterial walls (i.e., atherosclerosis).

    Clostridia and Enterobacteriaceae are the only two bacterial families common to the human gut microbiota that are known to produce TMAO, but only Enterobacteriaceae abundance is substantially increased on a high-fat diet. Oxygen content in the gastrointestinal tract decreases through the small and large intestines so that bacteria in the colon are mostly anaerobic (meaning they do not use oxygen for metabolism). This low oxygen environment is needed to promote the growth of more beneficial bacteria such as Clostridia and suppress the growth of more detrimental bacteria such as Enterobacteriaceae. In order to maintain this low oxygen environment, the mitochondria of colon cells must consume high levels of oxygen; however, a diet high in saturated fat may impair mitochondrial function, facilitating the growth of TMAO-producing bacteria and increasing heart disease risk.

    The investigators performed their experiments using two mouse strains with altered gut microbiota: mice that do not carry Enterobacteriaceae in their gut microbiota (E. negative) and germ-free mice, which are raised in a sterile environment and do not have a microbiota. They fed mice either a high-fat (60 percent of calories from fat) or low-fat (10 percent of calories from fat) diet for 10 weeks. The main source of fat in the high-fat diet was lard with casein protein, sugar, and micronutrients added. The researchers added a choline supplement to both the high-fat and low-fat diets one week before administering a single dose of a probiotic containing E. coli, a member of the Enterobacteriaceae family, to both E. negative and germ-free mice. All mice consumed their assigned diet for a total of 14 weeks. The researchers measured changes to epithelial cells in the colon including mitochondrial metabolism, inflammation, and cancer signatures.

    Both E. negative and germ-free mice that gained weight on the high-fat diet had increased inflammation and cancer signatures, suggesting some of the detrimental diet effects were independent of the microbiota. Germ-free mice on a low-fat diet had colon epithelial cells with appropriately low levels of oxygen; however, germ-free mice on a high-fat diet had colon epithelial cells with increased oxygen levels and reduced mitochondrial metabolism. Following E. Coli exposure, E. negative mice fed a high-fat diet supplemented with choline gained more weight and had higher levels of oxygen, inflammation, and signatures of cancer in their colons than E. negative mice fed a low-fat diet. These changes were associated with an increased concentration of fecal E. coli. In germ-free mice exposed to E. coli, a high-fat diet supplemented with choline significantly increased serum TMAO levels compared to all other groups.

    These results elucidate the mechanisms by which diets high in saturated fat may contribute to heart disease through interactions with choline metabolism by the gut microbiota. However, there are several important factors to consider in translating these results into relevant information for humans. Mouse diets often contain just one or two sources of fat such as lard and soybean oil, as was used in this study. Human diets contain a wider variety of fats, including various saturated and unsaturated fats. These diets also often contain high amounts of simple sugars, such as the sucrose and maltodextrin used in this study. The diet used in this study is also not representative of a standard human diet and limits the ability to distinguish between the effects of saturated fat and sugar. So, while animal studies are a vital foundation for human research, they should not be the basis for individual health recommendations. To hear Dr. Rhonda Patrick review the evidence on saturated fat and heart disease, listen to this episode of the FoundMyFitness podcast.

  • Time-restricted eating involves restricting the timing of food intake to certain hours of the day (typically within an 8- to 12-hour time window) without an overt attempt to reduce caloric intake. Increasing the amount of time spent fasting each day has been used to treat metabolic diseases such as type 2 diabetes and high cholesterol, increase muscle mass, decrease fat mass, and improve exercise performance. Findings of a recent report demonstrate the beneficial effects of time-restricted eating on exercise performance in power athletes.

    Increasing muscle mass and decreasing fat mass is an important goal for many athletes because increasing their strength-to-mass ratio improves performance. While time-restricted eating is one strategy to improve body composition, previous research has shown that other types of intermittent fasting (e.g., religious fasting during Ramadan) decrease power output and endurance. Another study involving intermittent fasting with caloric restriction found similar deficits in athletic performance. The effects of long-term time-restricted eating without caloric restriction are unknown.

    The researchers recruited healthy young males who were currently practicing a power-sport at least three times per week and had been practicing for at least three years. Twelve participants (average age, 22 years) completed four weeks of time-restricted eating and four weeks of a standard meal pattern in random order with two weeks of wash-out in between. During the time-restricted eating period, participants consumed all of their food within an eight-hour window. The researchers measured body composition using X-ray and athletic performance using the Wingate test, a cycling challenge that measures power and total work.

    Time-restricted eating produced a significant increase in total work (a measure of force over a set distance) and average power output (a measure of work over time). These improvements translated to a one second reduction in sprinting time. The participants achieved this change after four weeks of time-restricted eating, but not after one week. Time-restricted eating did not improve peak power, endurance, or body composition.

    Time-restricted eating, along with regular training, improved exercise performance in athletes. Given that the difference between the current and former 400 meter running world records is only 15 hundredths of one second, the one second decrease in sprinting time produced by time-restricted eating is meaningful.

  • A Western diet pattern, characterized by a low intake of fruits and vegetables and a high intake of sugar and processed foods, promotes the development of obesity and metabolic disease. Time restricted eating has been shown to decrease weight and improve metabolic health in humans. However, factors such as age and sex modulate both susceptibilty to obesity and likelihood of responding to weight-loss treatments. Authors of a new report found that male mice experienced greater metabolic benefit from time-restricted feeding than females.

    Time-restricted eating, the practice of limiting food intake to an 8- or 12-hour window, is an emerging therapy for the treatment and prevention of metabolic diseases. Much of the research about time-restricted eating in humans is based on research of time-restricted feeding in mice, which has elucidated many of the cellular mechanisms related to [time-restricted eating’s benefits.](​​https://journals.physiology.org/doi/full/10.1152/ajpregu.00775.2005) These two terms distinguish which population, humans or non-human animals, is practicing time-restricted food intake.

    The prevalence of obesity is on the rise in the industrialized world, a problem compounded by an increasing average age in the same populations. The accumulation of extra fat throughout life puts a person at greater risk of metabolic disease as they age. Females are more likely to gain and retain fat mass than males; however, pre-menopausal females tend to have lower rates of type 2 diabetes and cardiovascular disease due to the protective effects of estrogen. Previous research in humans has demonstrated weight loss and improved metabolic health with time-restricted eating; however, additional research is needed to understand the sex- and age-dependent effects of time-restricted eating.

    The researchers used male and female mice of two ages: three months old (equivalent to 20-year-old humans) and 12 months old (equivalent to 42 year-old-humans). They fed mice a chow diet representative of a Western diet pattern with 17 percent of calories from sugar (human equivalent of about 25 ounces of soda per day) and 45 percent of calories from fat including lard and soybean oil. Current dietary guidelines recommend limiting solid fats such as lard). Half of the mice had 24-hour access to food while the other half only had restricted access, limited to just nine hours per day. Mice continued their diet for a total of 12 to 13 weeks. After 10 weeks, the researchers measured changes in the animals' body weight, glucose sensitivity, serum cholesterol, fatty liver, muscle performance, and immune response when challenged with bacterial endotoxin.

    Although mice in the time-restricted feeding group consumed the same amount of food as mice with constant access to food, time-restricted feeding resulted in 15 percent less weight gain in young male mice and 23 percent less weight gain in older male mice. Time-restricted feeding did not significantly prevent weight gain in female mice. Male mice also experienced a greater reduction in serum cholesterol with time-restricted feeding compared to females. Both older male and female mice had lower rates of insulin resistance and fatty liver while on time-restricted feeding. This protection was likely due to changes in gene expression that increased glucose uptake by and decreased glucose output from the liver. In young male mice, time-restricted feeding preserved muscle mass, function, and performance, but not in young females. Finally, when challenged with bacterial endotoxin, older mice practicing time-restricted feeding were significantly more likely to survive septic shock than mice with 24-hour access to food, demonstrating better health and resilience.

    Time-restricted feeding improved survival of septic shock and provided protection against insulin resistance and fatty liver in both sexes; however, male mice experienced greater reductions in body weight and serum cholesterol and maintained greater muscle mass and performance compared to female mice. The authors noted that their research is of particular interest considering the increased risk of severe COVID-19 illness in those with poor metabolic health.

  • Exercise puts a demand on skeletal muscle cells to produce energy at a faster rate than at rest. To do this, the body increases the delivery of fats to the muscle mitochondria while increasing the mitochondrial capacity to metabolize fats, a process called beta-oxidation. Researchers of a new study aimed to illuminate the cellular mechanisms of mitochondrial fat metabolism following moderate intensity aerobic exercise.

    Mitochondria are cellular structures responsible for the production of energy in the form of adenosine triphosphate (ATP). The inner membrane of mitochondria possess a series of enzymes called the electron transport chain. These enzymes transfer electrons from carbohydrates and fats (as well as proteins and nucleic acids to a lesser extent) to the final enzyme in the chain that produces ATP. Electron transfer flavoprotein is an enzyme in this chain that transfers electrons from fats, specifically. The authors of this report have previously presented data demonstrating an increase in electron transfer flavoprotein activity in mice after aerobic exercise training.

    The investigators recruited fifteen healthy sedentary adults (average age, 28 years) with a normal body mass index. Participants completed one hour of cycling at 65 percent of their maximum aerobic capacity on one day and rested the next day. The researchers collected biopsies from the participants' thigh muscle after they had rested and 15 minutes after they exercised. They analyzed the muscle mitochondria for the abundance of electron transfer flavoprotein activity and for the metabolism of fats and nonfat fuel sources.

    Following exercise training, mitochondrial metabolism of fats and non-fat sources increased, although this relationship was not statistically significant. Also noted was a six percent increase in hydrogen peroxide, which is a byproduct of fat metabolism that damages cells. Although fat metabolism increased, the authors reported no increase in electron transfer flavoprotein activity abundance.

    They authors concluded that just one session of moderate intensity aerobic exercise in sedentary adults increases energy metabolism of both fats and non-fat sources. They suggested future research would include a larger sample of participants.

  • From the article:

    “Up to now the only known approach to inducing brown fat has been through exposure to chronic cold. Our research reveals a novel way of doing this without cold exposure. We show that animals living in an enriched environment become lean and resistant to diet-induced obesity, even in the presence of unlimited food.”

    […]

    The current study used a similarly designed environment, with 15-20 mice housed in large containers equipped with running wheels, tunnels, huts, wood toys, a maze, and nesting material, in addition to unlimited food and water.

    Key findings include the following:

    • Enriched animals showed a significant reduction in abdominal white fat mass (49 percent less than controls).

    • Exercise (running in a wheel) alone did not account for the changes in body composition and metabolism of enriched animals.

    • Fed a high fat diet (45 percent fat), enriched animals gained 29 percent less weight than control mice and remained lean, with no change in food intake. Enriched animals also had a higher body temperature, suggesting that greater energy output, not suppressed appetite, led to the resistance to obesity.

  • Scientists find that visceral fat, a type of adipose tissue that produces high levels of inflammatory signals known as adipokines, impair learning and memory in mice by setting off an inflammatory cascade mediated by the release of IL-1 beta, which crosses the blood-brain barrier leading to chronic activation of microglia.

    From the article:

    “We have identified a specific signal that is generated in visceral fat, released into the blood that gets through the blood brain barrier and into the brain where it activates microglia and impairs cognition.”

    Visceral fat as the ring leader:

    They looked further and found that just transplanting the visceral fat caused essentially the same impact as obesity resulting from a high-fat diet, including significantly increasing brain levels of interleukin-1 beta and activating microglia. Mice missing interleukin-1 beta’s receptor on the microglia also were protected from these brain ravages.

    […]

    To measure cognitive ability, the scientists looked at mice’s ability to navigate a water maze after 12 weeks on a high- or low-fat diet. They found it took the normal, or wild type, mice consuming the higher fat diet as well as the visceral transplant recipients with NLRP3 intact longer to negotiate the water maze. In fact, while they could reach a platform they could see, they had trouble finding one beneath the water’s surface that they had been taught to find. Mice with the interleukin-1 receptor knocked out, could find it just fine, Stranahan says.

    The high-fat diet, transplant mice also had weaker connections, or synapses, between neurons involved in learning and memory. Mice on a high-fat diet but missing NLRP3 were spared these changes, like mice on a low-fat diet.

  • From the article:

    “It’s true that vitamin C does react with oxidized lipids to form potential genotoxins,” said Balz Frei, professor and director of the Linus Pauling Institute, and co-author on this study. “But the process does not stop there. We found in human studies that the remaining vitamin C in the body continues to react with these toxins to form conjugates - different types of molecules with a covalent bond - that appear to be harmless.

    In human tests, the OSU scientists found in blood plasma extraordinarily high levels of these conjugates, which show this protective effect of vitamin C against toxic lipids.

    “Prior to this, we never knew what indicators to look for that would demonstrate the protective role of vitamin C against oxidized lipids,” Stevens said. “Now that we see them, it becomes very clear how vitamin C can provide a protective role against these oxidized lipids and the toxins derived from them. And this isn’t just test tube chemistry, this is the way our bodies work.

  • Fluid intelligence – the ability to creatively solve problems without prior knowledge or learning – declines with age, often as early as the third decade of life. Evidence from a new study suggests that body composition influences declines in fluid intelligence, and these declines may be related to immune system activation.

    Body composition describes an individual’s body fat and lean mass. Excess body fat promotes systemic inflammation (which can promote neuroinflammation) and drives immune-related inflammatory processes. Lean muscle mass, however, may be protective against inflammation.

    The study involved more than 4,400 middle-aged and older men and women living in the United Kingdom. The participants' body composition, cognitive function, blood leukocytes (white blood cells), and variables such as age, education level, and socioeconomic status were measured every other year for a period of six years.

    The authors of the study found that higher levels of body fat, especially abdominal fat, were associated with greater losses of fluid intelligence. The losses appeared to be related to sex-specific increases in blood leukocyte counts and inflammation, as evidenced by higher levels of C-reactive protein.

    These findings point to the importance of maintaining a healthy body weight throughout life as a strategy to reduce or prevent cognitive decline.

  • For the last year and a half, I have been on a ketogenic diet. Admittedly, it was heavy on saturated fat from dairy. Recently discovered that I have hypofunctioning PPAR-alpha genetics. Which now makes perfect sense because I could never get my ketones above 1 mmol, and my LDL skyrocketed (~190 on NMR, 86 when not in ketosis). Obviously, there were negatives to that dietary approach for me, but there were also a lot of positives. Not to mention, I would like to take advantage of the potential for longevity, decreasing cancer risk, etc that the ketogenic diet holds. Since learning this info (on top of the not so stellar labs), I have transitioned to a more Mediterranean diet with an emphasis on PUFA and MUFA. I’ve thought about doing periods of ketosis and fasting every now and then, while using PPAR-alpha agonists (like sesamin) to offset the genetic hypofunctioning. Would really like to get some insight on the safety, efficacy, etc of doing this.

  • You probably already know that ambient light regulates circadian rhythms by interacting with light-sensitive neurons in the eye.

    But let’s review anyway: In full white light (which contains all colors of light), the rays of the blue and green light spectrum activate melanopsin, a photosensitive protein in specific cells of the retina in the back of the eye. When light hits these cells, a signal transmits information to the brain’s master clock. By detecting various intensities and tones of light, the brain can keep track of what time of day it is.

    This is relatively well established. We also know that sunlight can stimulate the production of vitamin D and nitric oxide, both of which have important effects on health. But are these all of the effects that light has on our physiology?

    It has been known for several decades that a small percentage of blue light can penetrate human skin, and can even reach white subcutaneous adipose tissue. But the relevance of this finding on our physiology was not obvious.

    Curiously, it has also been reported that high OPN4 (the gene that encodes the photopigment melanopsin) mRNA levels are found in human subcutaneous fat. Kind of weird: what the heck are these light-sensitive eye proteins doing in our fat tissue? Additionally, we now know that fat cells contain transient receptor potential cation (TRPC) channels – membranes that are found in the retina that open in response to varying intensities of light.

    So, we know that blue light can get to subcutaneous fat tissue, and fat cells seem to have the machinery needed to respond to the signal that is transmitted by light. Very interesting. Is it possible that visible light penetrates the skin, and exerts physiological effects by activating a melanopsin / TRPC channel signaling pathway in human fat? And if so, could exposure to visible light have an impact on the regulation of body fat? The answer appears to be yes.

    My guest in this episode (inadvertently) found the answer to this novel questions…

  • Consuming more than one low-fat but not high-fat dairy product per day was associated with a 35-40% increased risk of developing Parkinson’s disease compared to those that had less than one serving of low-fat dairy.

    The overall risk of developing Parkinson’s disease was still quite low. Out of the 5,830 trial participants that consumed low-fat dairy only 1% of developed Parkinson’s. The 77,864 people who consumed less than one serving of low-fat dairy per day only 0.6% developed Parkinson’s disease.

    While this is an interesting observation (particularly since the finding was limited to low-fat dairy and not high fat), there is still much more to explore. Since this was not a controlled trial and the study did not control for other confounding factors (since it was looking at baseline characteristics) it is possible that other things associated with low-fat dairy consumption may increase Parkinson’s risk. For example, people that eat low-fat dairy products also may be more likely to consume other low-fat products, many which historically have had transfats in them. More research needs to be done before any conclusions can be made.

  • A small clinical trial finds that eating later in the day (12 pm to 11 pm) increased weight gain, raised insulin, fasting glucose, cholesterol, and triglyceride levels compared to eating earlier in the day (8 am to 7 pm).

    In the small study, each of the nine healthy weight adults underwent each of the two conditions: daytime eating (three meals and two snacks between 8 a.m. and 7 p.m.) for eight weeks and delayed eating (the same three meals and two snacks eating from noon to 11 p.m.) for eight weeks after a 2-week washout period. This is a small trial and needs to be repeated but is in line with another study that showed when healthy adults eat meals that are identical for breakfast, lunch, or dinner, the postprandial glucose increase is lowest after breakfast and highest after dinner even though the meals were 100% identical.

    For more on meal timing and time-restricted eating…check out my podcasts with the experts, Dr. Satchin Panda and Dr. Ruth Patterson on youtube and iTunes.